DEFM14A: Confluent to Merge with IBM in $31.00 Cash Deal

Sentiment:

Definitive Proxy Statement


Confluent, Inc. stockholders will vote on a proposed acquisition by IBM for $31.00 per share in cash, representing a significant premium.

Better than expectedThe merger consideration of $31.00 per share represents a substantial premium of approximately 35% to Confluent's 30-day volume-weighted average price as of December 5, 2025.IBM increased its offer price three times during the negotiation process, indicating a strong commitment and a willingness to pay a higher valuation.The unanimous recommendation by the independent Special Committee and the full Confluent Board suggests that the offer provides the best value reasonably obtainable for stockholders, offering immediate liquidity and certainty.

Summary

  • Confluent, Inc. (CFLT) is set to be acquired by International Business Machines Corporation (IBM) through a merger with Corvo Merger Sub, Inc., a wholly owned subsidiary of IBM.
  • Each outstanding share of Confluent Class A and Class B common stock will be converted into the right to receive $31.00 in cash, without interest and less any applicable withholding taxes.
  • This per-share price represents a premium of approximately 35% to Confluent's 30-day volume-weighted average price as of December 5, 2025.
  • The Special Committee, consisting solely of independent directors, unanimously declared the merger advisable, fair, and in the best interests of Confluent and its stockholders.
  • The Confluent Board of Directors, acting upon the Special Committee's recommendation, unanimously approved and recommended the merger agreement.
  • A special meeting of stockholders will be held virtually on February 12, 2026, at 9:00 a.m. Pacific Time, to vote on the merger agreement, a non-binding advisory proposal on executive compensation, and a proposal to adjourn the meeting if necessary.
  • Stockholders representing approximately 61.1% of the total voting power as of January 7, 2026, have entered into a voting agreement to vote in favor of the merger.
  • The merger is currently expected to be completed by the middle of 2026.
  • Confluent equity awards (Stock Options and Restricted Stock Units) will either be cashed out or converted into IBM restricted stock units, subject to specific terms.
  • The Confluent 2021 Employee Stock Purchase Plan (ESPP) will be terminated, with current participants' contributions used to purchase shares prior to closing.

Sentiment

Score: 8

Explanation: The filing outlines a definitive merger agreement with a significant cash premium for stockholders, unanimously recommended by the Board and Special Committee after a thorough process. This indicates a highly favorable outcome for current investors, providing immediate liquidity and de-risking future operations. While standard merger risks are present, the overall tone and terms are strongly positive for the acquisition.

Positives

  • The merger consideration of $31.00 per share in cash provides immediate liquidity and certainty of value for Confluent stockholders, eliminating risks and uncertainties associated with continuing as a standalone company.
  • The $31.00 per share represents a significant premium of approximately 34% to Confluent's closing stock price on December 5, 2025, and approximately 35% to its 30-day volume-weighted average price as of the same date.
  • The offer also represents a premium of approximately 52% to Confluent's 90-day volume-weighted average stock price as of December 5, 2025.
  • The merger is the result of a thorough strategic review process, including outreach to 20 potential bidders (9 financial sponsors and 11 strategic acquirers), with IBM being the only party to make a firm acquisition proposal.
  • IBM increased its offer price three times during negotiations, indicating a strong commitment and suggesting the final price is the highest reasonably obtainable.
  • IBM's strong business reputation and financial resources, including its intention to pay the aggregate price from cash on hand, support a high likelihood of successful and expedited consummation without financing conditions.
  • Confluent's customers are expected to benefit from IBM's complementary product offerings and greater resources and capabilities.
  • Transition and retention plans for certain Confluent employees are in place, which could help ensure management continuity and successful post-merger operations.
  • Appraisal rights are available to stockholders who do not vote in favor of the merger and properly exercise their rights under Delaware law.

Negatives

  • Confluent stockholders will not participate in any future earnings or growth of Confluent as an independent company following the merger.
  • The merger agreement includes restrictions on Confluent's ability to solicit alternative acquisition proposals.
  • There is a risk that regulatory agencies may delay, object to, challenge, or seek to enjoin the merger, or impose unacceptable conditions, potentially leading to non-consummation without compensation from IBM.
  • Certain significant stockholders, representing approximately 61.1% of the voting power, are contractually obligated to vote in favor of the merger, which could limit the influence of other stockholders or the viability of alternative offers.
  • If the merger is not completed, Confluent's directors, management, and employees will have expended significant time and effort, incurred substantial costs, and may face adverse impacts on business relationships and stock price decline.
  • Confluent is required to pay IBM a termination fee of $453,600,000 under certain circumstances, which could deter other potential bidders.
  • Interim restrictions on Confluent's business operations between signing and closing may prevent the company from pursuing new business opportunities.
  • The public announcement of the merger could lead to litigation and impact the company's ability to attract and retain key personnel.
  • The receipt of cash in exchange for shares will generally be a taxable transaction for U.S. federal income tax purposes for U.S. holders.

Risks

  • The possibility that the conditions to the closing of the merger are not satisfied (or waived), including the risk that required approvals from stockholders or regulatory bodies are not obtained, on a timely basis or at all.
  • The occurrence of any event, change, or other circumstance that could give rise to the right to terminate the merger agreement, including in circumstances requiring Confluent to pay a termination fee of $453,600,000.
  • Uncertainties as to the timing of the consummation of the merger and the ability of each party to consummate the merger.
  • The nature, cost, and outcome of any legal proceeding that may be instituted against Confluent and others relating to the merger.
  • Global economic volatility, macroeconomic political, legislative, and regulatory developments, geopolitical conflict or competitive pressures, or changes in such conditions, negatively affecting Confluent's markets, customers, business, operations, and financial performance.
  • The effect of the announcement or pendency of the merger on Confluent's business partners or other business relationships, customers, operating results, and business generally, and the response of competitors to the merger.
  • Possible disruption related to the merger to Confluent's ongoing business operations and opportunities, including risks related to the loss of customers and the diversion of the time and attention of Confluent management or employees during the pendency of the merger.
  • Risks that the pendency of the merger affects Confluent's current operations or its ability to retain or recruit employees.
  • The amount of the costs, fees, expenses, and charges related to the merger agreement or the merger.
  • The risk that Confluent's stock price may fluctuate during the pendency of the merger and may decline significantly if the merger is not completed on the terms reflected in the merger agreement, or at all.
  • The restraints on Confluent's ability to solicit other acquisition proposals from third parties during the pendency of the merger.
  • The reality that Confluent will forgo the opportunity to realize the potential long-term value of the successful execution of its current strategy as an independent company if the merger is completed.
  • Challenges to acquiring new customers and retaining existing customers, including competition from well-established cloud service providers and other companies in Confluent's ecosystem.
  • Rapid technological change, frequent new product and service introductions and enhancements, changing customer demands, and evolving standards that characterize Confluent's industry.
  • Challenges to increasing revenue growth while maintaining and improving operating margins, along with evolving investor expectations regarding profitability.
  • The ability to accurately forecast future financial performance.
  • The need to attract, retain, and motivate talented senior management and other strategic talent in order to successfully execute Confluent's business plan.
  • The fair value of shares determined by appraisal could be more than, the same as, or less than the per share price.

Future Outlook

The merger is expected to be completed by mid-2026, subject to the satisfaction or waiver of closing conditions, including stockholder and regulatory approvals. If the merger is not completed, Confluent will remain an independent public company, continuing to operate its business and file periodic reports with the SEC. However, if the merger fails, there is no assurance as to the future trading price of Confluent's Class A common stock, which may decline significantly, and the company's business, prospects, or results of operations may be adversely impacted.

Management Comments

  • Jay Kreps (Chief Executive Officer and Chairman): 'On behalf of Confluent's Board of Directors, thank you for your support.'

Industry Context

Confluent is a data streaming platform that is pioneering a new category of data infrastructure, designed to enable real-time data streams across organizations. IBM is a leading provider of global hybrid cloud and AI, and consulting expertise, serving clients in over 175 countries across critical infrastructure areas like financial services, telecommunications, and healthcare. The acquisition of Confluent by IBM is positioned to enhance IBM's hybrid cloud and AI platform by integrating Confluent's real-time data streaming capabilities, potentially strengthening IBM's competitive edge in digital transformation solutions. The industry is characterized by rapid technological change, frequent new product introductions, and intense competition from established cloud service providers.

Comparison to Industry Standards

  • Morgan Stanley's public trading comparables analysis included companies such as Atlassian Corporation, C3.ai Inc., Cloudflare, Inc., CrowdStrike Holdings, Inc., Datadog, Inc., Dynatrace, Inc., Elastic N.V., GitLab Inc., MongoDB, Inc., Okta, Inc., Palantir Technologies Inc., Snowflake Inc., UiPath, Inc., Unity Software Inc., and Zscaler, Inc., comparing their AV/CY2026E Revenue multiples.
  • Morgan Stanley's selected precedent transactions analysis reviewed similar software transactions since January 1, 2019, including acquisitions like Anaplan by Thoma Bravo, Medallia by Thoma Bravo, HashiCorp by IBM, Splunk by Cisco Systems, and Zendesk by Hellman & Friedman LLC and Permira Advisers LLC, noting their aggregate value to next 12-month revenue multiples.
  • The termination fee of $453,600,000 was assessed as reasonable and consistent with or below similar fees payable in comparable transactions.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
President, Field OperationsErica SchultzMay 22, 2025Cessation of employment
Melanie VinsonJune 12, 2025Cessation of employment
Chief Technology OfficerChad VerbowskiNovember 26, 2024Retirement (remained advisor through Feb 21, 2025)
Directors of Surviving CorporationConfluent DirectorsDirectors of Corvo Merger Sub, Inc.Effective Time of MergerMerger completion
Officers of Surviving CorporationConfluent OfficersOfficers of Corvo Merger Sub, Inc.Effective Time of MergerMerger completion (unless otherwise determined by IBM)
Chief Executive OfficerJay KrepsUpon ClosingEntered into a long-term retention offer letter with IBM.
Chief Financial OfficerRohan SivaramUpon ClosingEntered into a transition offer letter with IBM.
Ryan Mac BanUpon ClosingEntered into a transition offer letter with IBM.
Stephanie BuscemiUpon ClosingEntered into a transition offer letter with IBM.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Special Committee FormationThe Confluent Board established a Special Committee of independent directors (Lara Caimi, Greg Schott, Eric Vishria, Michelangelo Volpi) to evaluate, negotiate, and make recommendations regarding potential strategic opportunities, including a sale of Confluent. The Board delegated full power and authority to this committee and committed not to approve any transaction without its prior favorable recommendation.July 9, 2025Ensured independent oversight and fiduciary duty compliance in evaluating strategic alternatives.
Management Neutrality GuidelinesThe Confluent Board adopted management neutrality guidelines prohibiting any member of Confluent management from discussing future compensation, employment, consulting, or similar arrangements with a potential acquirer without the prior approval of the Special Committee.October 24, 2025Aimed to prevent conflicts of interest and ensure management's focus remained on stockholder value during the strategic review process.
Certificate of Incorporation AmendmentAt the effective time of the merger, Confluent's Certificate of Incorporation will be amended and restated to reflect its status as a wholly owned subsidiary of IBM, with a total authorized stock of 10,000 shares of Common Stock.Effective Time of MergerFormalizes Confluent's new corporate structure as a private entity under IBM, eliminating public shareholder rights and governance.
Bylaws AmendmentAt the effective time of the merger, Confluent's Bylaws will be amended and restated to align with its status as a wholly owned subsidiary of IBM.Effective Time of MergerAligns internal corporate governance with the new ownership structure, removing provisions relevant to a publicly traded company.

Legal Proceedings

  • The filing notes the possibility of 'Transaction Litigation' against Confluent or its directors relating to the merger or other contemplated transactions. Confluent has agreed to provide IBM prompt notice of any such litigation, give IBM the opportunity to participate in the defense, and consult with IBM on settlement.
  • If the merger is not completed, the contractual and legal remedies available to Confluent if IBM were to seek to terminate the merger agreement or abandon the merger may be insufficient, costly to pursue, or both.

Related Party Transactions

  • Simultaneously with the execution of the merger agreement, certain stockholders, including Jay Kreps (CEO and Chairman), Neha Narkhede, and certain affiliates of Jun Rao, entered into a voting agreement with IBM, Sub, and Confluent. These stockholders, representing approximately 61.1% of the voting power as of January 7, 2026, agreed to vote their shares in favor of the merger agreement and related transactions.
  • Confluent's directors and executive officers have interests in the merger that are different from, or in addition to, the interests of general stockholders. These include the treatment of their outstanding Confluent equity awards (cashed out or converted to IBM RSUs), potential severance payments under existing arrangements, and new employment/retention offer letters with IBM (for Jay Kreps, Rohan Sivaram, Ryan Mac Ban, and Stephanie Buscemi).
  • The Special Committee and Confluent Board were aware of and considered these interests when evaluating and recommending the merger.

Stakeholder Impact

  • **Shareholders**: Will receive $31.00 in cash per share, providing immediate liquidity and a significant premium over recent trading prices. They will no longer hold equity in Confluent and will not participate in its future growth as part of IBM. Stockholders who do not vote in favor of the merger may exercise appraisal rights.
  • **Employees**: Continuing employees will receive base salary/wages and target cash incentive opportunities no less favorable than prior to the merger for one year, and substantially comparable retirement and welfare benefits. Certain executives have entered into specific retention and transition offer letters with IBM, including new IBM restricted stock units for the CEO, Jay Kreps.
  • **Customers**: Expected to benefit from IBM's complementary product offerings and greater resources and capabilities, potentially leading to enhanced product development and support.
  • **Suppliers/Business Partners**: Relationships may be adversely affected by the announcement or pendency of the merger, as noted in the risks section.
  • **Creditors**: IBM expects to fund the acquisition from its cash on hand, suggesting a stable financial backing for the transaction, which is generally positive for creditors.

Next Steps

  • Confluent will prepare and file the preliminary Proxy Statement with the SEC.
  • Confluent will respond to any SEC comments and, once cleared, mail the definitive Proxy Statement to stockholders.
  • A special meeting of stockholders will be held on February 12, 2026, for stockholders to vote on the merger agreement, advisory executive compensation, and potential meeting adjournment.
  • IBM and Confluent will continue to seek necessary regulatory clearances, including under the HSR Act and other antitrust/foreign investment laws.
  • The merger is expected to close by mid-2026, assuming all conditions are met.
  • If the merger is completed, Confluent's common stock will be delisted from Nasdaq and deregistered under the Exchange Act.

Key Dates

DateDescription
May 22, 2025Erica Schultz ceased employment with Confluent.
June 12, 2025Melanie Vinson ceased employment with Confluent.
December 1, 2025Corvo Merger Sub, Inc. (Sub) was formed.
December 5, 2025Last trading day prior to the announcement of the transaction, used for premium calculation.
December 7, 2025Merger Agreement signed; Morgan Stanley rendered its oral opinion; Confluent Board approved the merger; Voting Agreement executed; Executive retention and transition arrangements finalized.
December 8, 2025Confluent and IBM jointly publicly announced the merger.
December 12, 2025IBM and Confluent filed a Premerger Notification and Report Form under the HSR Act.
December 15, 2025Beneficial ownership record date for the security ownership table.
January 5, 2026Date for calculating outstanding equity awards and shares held by directors and executive officers.
January 7, 2026Record date for stockholders entitled to notice of, and to vote at, the special meeting.
January 9, 2026Proxy statement dated and first sent to stockholders.
January 12, 2026Expected expiration of the initial 30-day HSR Act waiting period (unless shortened or extended).
February 12, 2026Special Meeting of Stockholders to be held virtually at 9:00 a.m. Pacific Time.
Mid-2026Expected completion of the merger.
December 7, 2026Initial Termination Date for the merger agreement, if the merger has not been consummated.
March 7, 2027First Extended Termination Date, if regulatory conditions are the only outstanding conditions by the Initial Termination Date.
June 7, 2027Second Extended Termination Date, if regulatory conditions are the only outstanding conditions by the First Extended Termination Date.

Recommendation

strong buy

The proposed acquisition of Confluent by IBM at $31.00 per share represents a substantial premium of approximately 35% over Confluent's 30-day volume-weighted average price. This all-cash offer provides immediate and certain value to stockholders, de-risking their investment from future market volatility and execution challenges. The unanimous recommendation by an independent Special Committee and the full Board, coupled with IBM's willingness to increase its offer multiple times, indicates that this is a highly favorable and well-negotiated outcome. The voting agreement from major stockholders further solidifies the likelihood of the merger's approval. For investors, this offers a compelling exit at a premium valuation.

Keywords

Confluent, IBM, Merger, Acquisition, Cash Offer, Stockholder Vote, Proxy Statement, SEC Filing, Data Streaming, Cloud, AI, Corporate Governance, Risk Management, Financial Analysis, Shareholder Value, Antitrust, Regulatory Approval, Executive Compensation, NASDAQ, CFLT

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.